ストックスクリーナーアプリを入手
80.95
0.24%
0.19
アフターアワーズ：
80.95
前日終値:
$80.76
開ける：
$80
24時間の取引高:
209.96K
Relative Volume:
2.80
時価総額：
$499.46M
収益：
-
当期純損益:
$-7.12M
株価収益率:
-35.20
EPS:
-2.3
ネットキャッシュフロー:
$-6.82M
1週間 パフォーマンス:
-6.05%
1か月 パフォーマンス:
-17.83%
6か月 パフォーマンス:
+107.03%
1年 パフォーマンス:
+414.62%
1日の値動き範囲:
$77.82
$83.86
1週間の範囲:
$77.00
$86.16
52週間の値動き範囲:
$15.50
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
名前
Monopar Therapeutics Inc
セクター
電話
(847) 388-0349
住所
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
80.95 | 498.29M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-09-09 | 開始されました | BTIG Research | Buy |
| 2025-09-03 | 開始されました | Oppenheimer | Outperform |
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-08-26 | 再開されました | H.C. Wainwright | Buy |
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-19 | 再開されました | Piper Sandler | Overweight |
| 2025-01-10 | 開始されました | Piper Sandler | Overweight |
| 2024-10-11 | 開始されました | Rodman & Renshaw | Buy |
| 2021-01-28 | 開始されました | ROTH Capital | Buy |
すべてを表示
Monopar Therapeutics Inc (MNPR) 最新ニュース
Monopar Therapeutics announces pricing of $40M public offering of common stock - MSN
How Monopar Therapeutics Inc. (1IY0) stock correlates with oil marketsQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
Why Monopar Therapeutics Inc. stock attracts global investorsDip Buying & Verified Momentum Stock Watchlist - newser.com
What moving averages say about Monopar Therapeutics Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easing2025 EndofYear Setup & Technical Pattern Based Signals - newser.com
Top chart patterns to watch in Monopar Therapeutics Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
Monopar Therapeutics Inc. stock prediction for this weekMarket Activity Summary & Community Consensus Stock Picks - newser.com
Is Monopar Therapeutics Inc. stock entering bullish territoryJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Will Monopar Therapeutics Inc. stock deliver long term returnsTreasury Yields & Free Real-Time Volume Trigger Notifications - newser.com
Exit strategy if you’re trapped in Monopar Therapeutics Inc.July 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is Monopar Therapeutics Inc. forming a reversal patternTrade Analysis Report & Weekly Momentum Picks - newser.com
Heatmap analysis for Monopar Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
Applying sector rotation models to Monopar Therapeutics Inc.2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Why Monopar Therapeutics Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Is Monopar Therapeutics Inc. stock attractive for retirement portfoliosWall Street Watch & Verified Trade Idea Suggestions - newser.com
Monopar Therapeutics Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
When is the best time to exit Monopar Therapeutics Inc.2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
Has Monopar Therapeutics Inc. formed a bullish divergenceWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Multi factor analysis applied to Monopar Therapeutics Inc.Wall Street Watch & Risk Managed Investment Signals - newser.com
Monopar Therapeutics (NASDAQ:MNPR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Monopar Therapeutics Inc (MNPR) 財務データ
収益
当期純利益
現金流量
EPS
Monopar Therapeutics Inc (MNPR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R | Director |
Jul 14 '25 |
Sale |
40.00 |
8,904 |
356,171 |
11,486 |
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):